The devices used in this observational registry are the Osprey Medical Contrast Monitoring System (CMS) and the Osprey Medical AVERT Reflux Reduction System. Both products have CE Mark designations. The purpose of this registry is to evaluate the usability characteristics of the combined Osprey Medical AVERT System and the Contrast Monitoring System during normal clinical use.
This is a prospective, single-center, non-randomized, single arm, observational registry of the AVERT System used in combination with the Contrast Monitoring System. Patients undergoing manual manifold injection coronary artery imaging for diagnostic or PCI procedures that utilize the AVERT System and the CMS will be included in this registry. Device use characteristics including, measurement of contrast media volume used, contrast media volume saved by the use of the AVERT System, evaluation of angiographic image quality, and physician feedback on device features and function will be obtained. All data will be collected on the day of the procedure and there will be no long-term follow-up.
Study Type
OBSERVATIONAL
Enrollment
20
Universitatsklinikum Schleswig-Holstein (Campus Lubeck)
Lübeck, Germany
Contrast media volume usage
Compare cumulative contrast media volume usage as displayed by the CMS to volume estimation commonly performed in the catheterization laboratory
Time frame: Day of procedure
Contrast media volume savings
Use the displayed volume savings function of the Contrast Monitoring System to determine the percent reduction in contrast media delivered to the patient due to the use of the AVERT System.
Time frame: Day of procedure
Angiographic image quality
Time frame: Day of procedure
Physician feedback on device features
Time frame: Day of procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.